Fujifilm Diosynth

FUJIFILM Biotechnologies is a major, well-established CDMO within the FUJIFILM Corporation ecosystem, offering comprehensive development and manufacturing services for biologics and advanced therapies. It combines deep technical expertise in process development with a significant global footprint of manufacturing facilities, positioning itself as a 'Partner for Life' for biopharma companies. The company is backed by substantial investment from its parent company and is actively expanding its capabilities and geographic presence to capitalize on the growing outsourced biomanufacturing market.

Integrated CDMO platforms for mammalian cell culture, microbial fermentation, and cell & gene therapy (viral vectors). Proprietary purification technology (ShunzymeX™).

The company competes in a crowded global CDMO market with large players like Lonza, Catalent, and Samsung Biologics, as well as many specialized firms. Its key differentiators are the substantial financial backing of FUJIFILM, end-to-end service integration, and significant recent investments in capacity and proprietary technology like ShunzymeX™.